SCHEMBL7317029

SCHEMBL7317029

FC1CNCCN1C(c1ccccc1)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
OPRD1 P41143 11/20 0.42
USP2 O75604 3/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 1/20 0.41
OPRM1 P35372 3/20 0.38
OPRK1 P41145 3/20 0.38
OPRL1 P41146 3/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2D6 P10635 2/20 0.38
L3MBTL3 Q96JM7 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
TP53 P04637 1/20 0.37
ALOX15 P16050 1/20 0.37
NPSR1 Q6W5P4 1/20 0.36
GPR55 Q9Y2T6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4153276 0.81 MEN1 (0.53) MEN1KMT2AOPRD1USP2CYP2C9
SCHEMBL4153281 0.81 MEN1 (0.53) MEN1KMT2AOPRD1USP2CYP2C9
SCHEMBL9530935 0.80 MEN1 (0.51) MEN1KMT2AOPRD1USP2CYP2C9
SCHEMBL5623535 0.80 MEN1 (0.51) MEN1KMT2AOPRD1USP2CYP2C9
SCHEMBL3919530 0.79 MEN1 (0.50) MEN1KMT2AOPRD1USP2CYP2C9
SCHEMBL27994808 0.79 MEN1 (0.50) MEN1KMT2AOPRD1USP2CYP2C9
SCHEMBL8051571 0.76 MEN1 (0.47) MEN1KMT2AOPRD1USP2CYP2C9
SCHEMBL27402701 0.76 MEN1 (0.51) MEN1KMT2AOPRD1USP2CYP2C9
SCHEMBL27664880 0.75 MEN1 (0.42) MEN1KMT2AOPRD1CYP2D6SLC6A2
SCHEMBL5633854 0.74 OPRD1 (0.50) MEN1KMT2AOPRD1OPRM1SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0159566-A1 Novel piperazine derivatives, processes for production thereof, and pharmaceutical compositions comprising said compounds as active ingredient KANEBO, LTD. (JP) 1985-10-30 EP claimed
US-4663325-A 1-(2,3,4-tri-methoxybenzyl)-4[bis(4-fluorophenyl)methyl] piperazines are useful for treating cerebrovascular disease KANEBO LTD. (JP) 1987-05-05 US disclosed
US-4663325-A 1-(2,3,4-tri-methoxybenzyl)-4[bis(4-fluorophenyl)methyl] piperazines are useful for treating cerebrovascular disease KANEBO LTD. (JP) 1987-05-05 US disclosed
EP-0159566-A1 Novel piperazine derivatives, processes for production thereof, and pharmaceutical compositions comprising said compounds as active ingredient KANEBO, LTD. (JP) 1985-10-30 EP disclosed
EP-0159566-A1 Novel piperazine derivatives, processes for production thereof, and pharmaceutical compositions comprising said compounds as active ingredient KANEBO, LTD. (JP) 1985-10-30 EP disclosed